Ashley R. Paquin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ashley R. Paquin has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Christopher O. Eden
Department of Medicine, Oregon Health & Science University, Portland, OR
1 shared publication Emmanuella Oyogoa
Division of Internal Medicine Oregon Health and Science University Portland Oregon USA
1 shared publicationHannah L. King
Department of Internal Medicine, Oregon Health and Science University, Portland, Oregon
1 shared publication- Hannah Stowe McMurry
Division of Hematology and Medical Oncology, Knight Cancer Institute Oregon Health & Science University Portland Oregon USA
1 shared publication - Joseph J. Shatzel
Division of Hematology and Medical Oncology, Knight Cancer Institute
1 shared publication - Malinda T. West
OHSU Knight Cancer Institute, Oregon Health & Science University , Portland, OR , USA
1 shared publication
Latest Publications
- 1 November 2024
- Published by American College of Physicians in Annals of Internal Medicine: Clinical Cases
- Vol. 3 (11)
Intravascular Large B-Cell Lymphoma: A Case of Negative Biopsies and Hemophagocytic Lymphohistiocytosis
- 1 November 2024
- Published by American College of Physicians in Annals of Internal Medicine: Clinical Cases
- Vol. 3 (11)
Intravascular Large B-Cell Lymphoma: A Case of Negative Biopsies and Hemophagocytic Lymphohistiocytosis
- 25 September 2022
- Published by Wiley in European Journal of Haematology
- Vol. 110 (1) , 3-13
The diagnosis and management of suspected lymphoma in general practice
With rapid advancements in diagnosis and treatment of malignancies, the gap between generalists and subspecialists continues to widen, particularly in cancers like lymphoma where the spectrum of disease varies from indolent to rapidly progressive. Prior to establishing with a hematologist/oncologist, patients must be accurately and comprehensively diagnosed and managed for lymphoma in the generalist setting. In the following manuscript, we review the common clinical presentations in which should raise concern for lymphoma. We summarize the literature regarding the role of laboratory studies including complete blood count and peripheral blood flow cytometry, the recommendations for lymph node sampling, the role and selection of imaging modalities, and ideal patient monitoring for high‐risk clinical syndromes that may be encountered in lymphoma.
- 25 September 2022
- Published by Wiley in European Journal of Haematology
- Vol. 110 (1) , 3-13
The diagnosis and management of suspected lymphoma in general practice
With rapid advancements in diagnosis and treatment of malignancies, the gap between generalists and subspecialists continues to widen, particularly in cancers like lymphoma where the spectrum of disease varies from indolent to rapidly progressive. Prior to establishing with a hematologist/oncologist, patients must be accurately and comprehensively diagnosed and managed for lymphoma in the generalist setting. In the following manuscript, we review the common clinical presentations in which should raise concern for lymphoma. We summarize the literature regarding the role of laboratory studies including complete blood count and peripheral blood flow cytometry, the recommendations for lymph node sampling, the role and selection of imaging modalities, and ideal patient monitoring for high‐risk clinical syndromes that may be encountered in lymphoma.